Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences is a global medical technology company dedicated to patient-focused innovations for structural heart disease and critical care monitoring. The company is renowned for pioneering artificial heart valves, including advanced transcatheter aortic heart valves (TAVR) such as the Sapien system, and is actively expanding its portfolio in transcatheter mitral and tricuspid therapies (TMTT). Their offerings also encompass comprehensive hemodynamic monitoring solutions, which are crucial for managing critically ill patients.
Driven by a commitment to improving patient outcomes, Edwards Lifesciences collaborates extensively with leading clinicians and researchers to address unmet healthcare needs. A significant and growing area of focus for the company is the integration of artificial intelligence (AI) and machine learning into their products. This includes developing AI-powered algorithms for predictive monitoring in critical care, aiming to assist physicians in making timely, life-critical decisions, predicting adverse outcomes before they occur, and ultimately reducing complications for patients.
Focus Areas
Business Intelligence
| Key Investors | The Vanguard Group, BlackRock, State Street, Wellington Management, J.P. Morgan Asset Management, Jennison Associates, Geode Capital Management (as major institutional shareholders). |
| Partnerships | Philips (for AI-based guide for mitral valve repair with DeviceGuide), Bay Labs (for AI in cardiovascular imaging to improve heart disease detection) |
| Acquisitions | Valtech Cardio (2017), Harpoon Medical (2017), CAS Medical Systems (2019), Innovalve Bio Medical (2024), JenaValve Technology (2024), Endotronix (2024), JC Medical (2024), Vectorious Medical Tech (2023), Corvia Medical (2019), CardiAQ Valve Technologies (2015), BMEYE (2012), Embrella Cardiovascular (2011), Myocor (2008), Percutaneous Valve Technologies (2003). (Note: Edwards' Critical Care business was acquired by BD in 2024). |
| Technology | HemoSphere advanced hemodynamic monitoring platform with Acumen suite (Acumen HPI, Acumen AFM) utilizing machine learning and AI algorithms for predictive decision support and retrospective data analysis. Collaboration with Philips on DeviceGuide AI solution for real-time 3D visualization during mitral valve repair. |
| FDA Clearances | The Acumen suite of intelligent decision-support solutions on the HemoSphere advanced hemodynamic monitoring platform received U.S. FDA clearance in December 2018. The company's Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valve systems were FDA-approved in August 2019. cleared products (estimated) |
What Physicians Need to Know
Edwards Lifesciences stands out for physicians through its commitment to less invasive therapies, offering advanced solutions like TAVR and TMTT that can improve patient outcomes and reduce recovery times. Their deep integration of AI, particularly in predictive hemodynamic monitoring, provides clinicians with crucial, real-time insights to anticipate and proactively manage critical patient conditions, such as hypotension. The company's long-standing collaboration with physicians in research, development, and education ensures that their innovations are clinically relevant and supported by robust evidence. This focus on cutting-edge technology combined with comprehensive clinical support aims to enhance patient safety, optimize care pathways, and ultimately improve the quality of life for individuals with cardiovascular disease.
Edwards Lifesciences has historically focused on making its critical care parameters widely accessible through licensing and integration with various patient monitors, such as Philips IntelliVue. However, it's important to note that BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group in September 2024. This acquisition means that BD now offers these leading monitoring technologies, including advanced AI-enabled clinical decision tools, and aims for future innovation opportunities in closed-loop hemodynamic monitoring and IV fluid/medication administration by integrating combined company data sets and interoperability capabilities. For structural heart therapies and related AI, Edwards continues to develop and integrate its solutions, often through cloud-based platforms like CardioCare, which can incorporate AI algorithms for quality care navigation.
What the Web Says
Edwards Lifesciences generally receives positive to mixed reviews. Product reviews, particularly for their cardiovascular devices, highlight innovation and life-saving capabilities. Employer reviews often praise the company culture, mission-driven work, and benefits, but some employees express concerns about work-life balance and internal bureaucracy.
Overall: MixedStrengths
- Innovative and life-saving medical devices (e.g., TAVR)
- Strong company culture and mission-driven work
- Good benefits and compensation packages
- Opportunities for professional growth and development
- Positive impact on patient lives
- Collaborative work environment
Limitations
- Work-life balance can be challenging due to high demands
- Bureaucracy and slow decision-making in some departments
- Management effectiveness can vary by team
- High-pressure environment in certain roles
- Compensation may not always align with workload for some
- Internal communication issues reported by some employees
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News (general industry sentiment)
Last updated: 2026-07-17
Videos
News, demos, and interviews about Edwards Lifesciences.
Videos load interactively. If none appear, search YouTube for Edwards Lifesciences →
Press & Coverage
Frequently Asked Questions
Related Companies
Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]
TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]
TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]
Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]
Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]
SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]